A novel case study on safety and efficacy profile of intralesional vitamin D3 in the treatment of multiple cutaneous warts

S. Suganthi; Pichano E.  Khuvung; M. Aishwarya; A. Shivashankar

doi:10.18203/issn.2455-4529.IntJResDermatol20252551

Authors

S. Suganthi Department of Dermatology, Thanjavur Medical College and Hospital, Thanjavur, Tamil Nadu, India
Pichano E. Khuvung Department of Dermatology, Thanjavur Medical College and Hospital, Thanjavur, Tamil Nadu, India
M. Aishwarya Department of Dermatology, Thanjavur Medical College and Hospital, Thanjavur, Tamil Nadu, India
A. Shivashankar Department of Dermatology, Thanjavur Medical College and Hospital, Thanjavur, Tamil Nadu, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20252551

Keywords:

Immunotherapy, Verrucae, Induration

Abstract

Immunotherapy has now become one of the emerging therapeutic tools for treatment of multiple warts. In this case series we tried to analyse the safety and efficacy profile of intralesional vitamin D3, a novel immunotherapeutic agent. A total of 24 patients between 12 to 60 years having more than 3 cutaneous warts were included. Four patients lost follow up and 20 patients were studied. Each patient received 0.1 ml of vitamin D3 (15 mg/ml, 6L IU/ml) injected intralesionally into one wart, with a maximum of 5 warts treated. The injection is repeated 2 weeks once until complete resolution or total of 4 injections. The primary outcome measure is complete resolution of warts and return of normal skin markings. Out of 20 patients, 15 (75%) showed complete clearance. One patient showed recurrence during follow up period. Adverse effects are all minimal including erythema, induration and pain at the injection site. Injection vitamin D3 is a safer, inexpensive, easily available and effective immunotherapeutic agent for treatment of multiple warts. The injection site must be carefully selected to avoid disfiguring induration.

Metrics

Metrics Loading ...

References

Thappa DM, Chiramel MJ. Evolving role of immunotherapy in the treatment of refractory warts. Indian Dermatol Online J. 2016;7:364-70. DOI: https://doi.org/10.4103/2229-5178.190487

Chandrashekar L. Intralesional immunotherapy for the management of warts. Indian J Dermatol Venereol Leprol. 2011;77:261-3. DOI: https://doi.org/10.4103/0378-6323.79694

Nofal A, Nofal E. Intralesional immunotherapy of common warts: Successful treatment with mumps, measles and rubella vaccine. J Eur Acad Dermatol Venereol. 2010;24:1166-70. DOI: https://doi.org/10.1111/j.1468-3083.2010.03611.x

Silverberg NB, Lim JK, Paller AS, Mancini AJ. Squaric acid immunotherapy for warts in children. J Am Acad Dermatol. 2000;42:803-8. DOI: https://doi.org/10.1067/mjd.2000.103631

Gonçalves MA, Donadi EA. Immune cellular response to HPV: Current concepts. Braz J Infect Dis. 2004;8:1-9. DOI: https://doi.org/10.1590/S1413-86702004000100001

Dall’oglio F, D’Amico V, Nasca MR, Micali G. Treatment of cutaneous warts: an evidence-based review. Am J Clin Dermatol. 2012;13(2):73-96. DOI: https://doi.org/10.2165/11594610-000000000-00000

Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, et al. Toll-like receptor triggering of a Vitamin D-mediated human antimicrobial response. Science. 2006;311:1770-3. DOI: https://doi.org/10.1126/science.1123933

Moscarelli L, Annunziata F, Mjeshtri A, Paudice N, Tsalouchos A, Zanazzi M, et al. Successful treatment of refractory wart with a topical activated Vitamin D in a renal transplant recipient. Case Rep Transplant. 2011;2011:368623. DOI: https://doi.org/10.1155/2011/368623

Rind T, Oiso N, Kawada A. Successful treatment of anogenital wart with a topical Vitamin D(3) Derivative in an infant. Case Rep Dermatol. 2010;2:46-9. DOI: https://doi.org/10.1159/000312986

Inaba H, Suzuki T, Adachi A, Tomita Y. Succesful treatment of warts with a combination of maxacalcitol ointment and salicylic acid sticking plaster. J Dermatol. 2006;33:383-5. DOI: https://doi.org/10.1111/j.1346-8138.2006.00090.x

Singh SK, Mohan A, Gupta AK, Pandey AK. A comparative study between intralesional PPD and Vitamin D3 in treatment of viral warts. Int J Res Dermatol. 2018;4:197-201. DOI: https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20180953

Mittal N, Malhotra SK, Singh NR. Relative efficacy and safety of intralesional measles mumps rubella vaccine (MMR) and intralesional vitamin D in multiple and recalcitrant verrucae vulgaris. IP Indian J Clin Exp Dermatol. 2021;7(2):158-63. DOI: https://doi.org/10.18231/j.ijced.2021.030

Rehna A, Shweta PB, Badrinath N, Sachin MS, Aiswarya V. Comparative Study in Efficacy and Safety of Intralesional Injections of Vitamin D3, Measles Rubella (MR) Vaccine, and Purified Protein Derivative (PPD) in the Management of cutaneous warts. J Cutan Aesthet Surg. 2020;13(4):326-32. DOI: https://doi.org/10.4103/JCAS.JCAS_39_20

Raghukumar S, Ravikumar BC, Vinay KN, Suresh MR, Aggarwal A, Yashovardhana DP. Intralesional Vitamin D3 injection in the Treatment of Recalcitrant Warts: A Novel Proposition. J Cutan Med Surg. 2017;21(4):320-3. DOI: https://doi.org/10.1177/1203475417704180

Kavya M, Shashikumar BM, Haruish MR. Safety and efficacy of intralesional vitamin D3 in cutaneous warts: an open uncontrolled trial.J Cut Aesth Surg. 2017;10(2):90-4. DOI: https://doi.org/10.4103/JCAS.JCAS_82_16

Abou-Taleb DAE, El-Badaway O, Ahmed AO, Thabiet Hassan AE, Awad SM. Intralesional vitamin d3 vs intralesional PPD in treatment of multiple warts: A comparative clinical and immunological study. Dermatol Therapy. 2019;32:e13034. DOI: https://doi.org/10.1111/dth.13034

Shaldoum DR, Hassan GFR, EI Maadawy EH. Comparative clinical study of efficacy of intralesional MMR vaccine vs intralesional vitamin D injection in treatment of warts. J Cosmet Dermatol. 2020;00:1-8. DOI: https://doi.org/10.1111/jocd.13272

Samta S, Brar BK. Intralesional vitamin D3 for palmoplantar warts: A novel modality. Pak Dermatol. 2020;30:418-22.

Aktas H, Ergin C, Demir B, Ekiz O. intralesional vitamin D injection may be an effective trearment option for warts. JCutan Med Surg 2016;20:118-22 DOI: https://doi.org/10.1177/1203475415602841

Priya A, Adil M, Amin SS, Mohtashim M, Bansal R, Alam M. intralesional vitamin D3 in recalcitrant palmoplantar and periungual warts: A Prospective, observational study. Acta Dermatovenerol Croat. 2019;27(4):215-24.

Fathy G, Sharara MA, Khafagy AH. Intralesional vitamin D3 versus candida antigen immunotherapy in the treatment of multiple recalcitrant plantar warts. Dermatol Ther. 2019;32(5):e12997. DOI: https://doi.org/10.1111/dth.12997

Garg S, Baveja S. intralesional immunotherapy for difficult to treat warts with Mycobacterium W vaccine. J Cutan Aesthet Surg. 2014;7:203-8. DOI: https://doi.org/10.4103/0974-2077.150740

Singh S, Chouhan K, Gupta S. immunotherapy with killed Mycobacterium indicus pranii vaccine for treatment of extensive cutaneous warts. Indian J Dermatol Venereal Leprol. 2014;80:509-14. DOI: https://doi.org/10.4103/0378-6323.144145